7.     CUSTOMER CARD FUNDING LIABILITY

The Company issues prepaid cards with various provisions for cardholder fees or expiration. Revenue generated from cardholder transactions and interchange fees are recognized when the Company’s performance obligation is fulfilled. Unspent balances left on pharma cards are recognized as settlement income at the expiration of the cards and the program. Client prefunded amounts for patient affordability programs are amounts that will be used to fund pass-through cost for reimbursement claims. Contract liabilities related to prepaid cards, client funds held to be loaded to cards before the amounts are ultimately spent by the cardholders or recognized as revenue by the Company, and patient affordability client prefunded amounts represent funds on card. Contract liabilities related to prepaid cards and patient affordability prefunded amounts are reported as customer card funding liability on the consolidated balance sheet.

The opening and closing balances of the Company’s liabilities are as follows:

The amount of revenue recognized during the years ended December 31, 2025 and 2024 that was included in the opening liability for prepaid cards was $2,727,566 and $2,319,630, respectively. Customer card funding liability for the years ended December 31, 2025 and 2024 included patient affordability prefunded amounts of $57,301,119 and $35,444,648, respectively.